ConMed Beamer Study

Sponsor
Baylor College of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT04752670
Collaborator
ConMed Corporation (Industry)
60
1
11.1
5.4

Study Details

Study Description

Brief Summary

This is a prospective registry of all patients who endoscopic submucosal dissection (ESD), per-oral endoscopic myotomy (POEM) and gastric per-oral endoscopic myotomy (G-POEM) using ConMed Electrosurgical unit for submucosal Dissection at Baylor St Luke's Medical Center. Collected information includes; procedure technical success rate, duration, periprocedural complications and ease of use.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Submucosal endoscopy is a novel subset of procedures which enables endoscopist to utilize the submucosal space to perform advanced endoscopic procedures. The submucosa is the third layer of the gastrointestinal wall and it is a potential space which is expandable upon injecting the submucosa with fluid. The expanded submucosa causes a significant lift which enable dissection of the submucosal space with the removal of the overlying polyp or early cancer. The submucosal space can be also utilized to create a longitudinal submucosal tunnel in the esophagus or the stomach wall which allows for performing lower esophageal sphincter or pyloric myotomy for the treatment of achalasia or Gastroparesis.

    Currently, the most commonly performed submucosal endoscopy procedures are endoscopic submucosal dissection (ESD) for removal of early cancers or polyps throughout the gastrointestinal tract, Per-oral Endoscopic Myotomy (POEM) for treatment of achalasia, or Gastric Per-Oral Endoscopic myotomy for the treatment of Gastroparesis. All of the above procedures require a specialized electrosurgical unit (ESU) which generate high frequency current to help incision (cutting) of the mucosa and dissection (coagulation) of the submucosa. The ConMed Beamer is a novel ESU with tissue sensing property which expedites the process of submucosal dissection. The device is currently approved for clinical use in the US. The purpose of this study is to create registry for all submucosal endoscopy procedures performed using ConMed Beamer device at BSLMC with focus on clinical outcomes of the procedure including adverse events.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    60 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Prospective Registry of Submucosal Endoscopic Procedures Performed by a Novel Electrosurgical Unit
    Actual Study Start Date :
    May 27, 2021
    Actual Primary Completion Date :
    Mar 2, 2022
    Actual Study Completion Date :
    May 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Technical Success rate [1 year]

      Defined as the ability to perform the entire procedure using the ConMed Beamer electrosurgical system

    Secondary Outcome Measures

    1. Procedure Time [1 year]

      Determine length of time to perform procedure using ConMed Beamer electrosurgical system

    2. Adverse Events [1 year]

      Intraprocedural AE such as bleeding or perforation

    3. Adverse Events [1 year]

      Post procedural, post polypectomy, delayed bleeding or delayed perforation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patient is ≥ 18 years old

    • Patient is capable of providing informed consent

    • Patient is referred for endoscopic submucosal dissection, per-oral endoscopic myotomy, or gastric per-oral endoscopic myotomy

    Exclusion Criteria:
    • Patient is < 18 years old

    • Patient refused and/or unable to provide consent

    • Patient is a pregnant woman

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Baylor St. Lukes Medical Center (BSLMC) Houston Texas United States 77030

    Sponsors and Collaborators

    • Baylor College of Medicine
    • ConMed Corporation

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mohamed Othman, M.D. Director of Advanced Endoscopy Assistant Professor of Medicine - Gastroenterology Section, Baylor College of Medicine
    ClinicalTrials.gov Identifier:
    NCT04752670
    Other Study ID Numbers:
    • H-49160
    First Posted:
    Feb 12, 2021
    Last Update Posted:
    May 27, 2022
    Last Verified:
    May 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mohamed Othman, M.D. Director of Advanced Endoscopy Assistant Professor of Medicine - Gastroenterology Section, Baylor College of Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 27, 2022